Pendal Group LTD Bio Rad Laboratories, Inc. Transaction History

Pendal Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$463.67 - $597.16 $508,182 - $654,487	-1,096 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$524.57 - $735.42 $574,928 - $806,020	1,096 New	1,096 $617,000
Q4 2020 Jan 21, 2021	SELL	$510.68 - $643.45 $268,617 - $338,454	-526 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$454.43 - $535.6 $521,231 - $614,333	-1,147 Reduced 68.56%	526 $271,000
Q2 2020 Aug 07, 2020	BUY	$334.87 - $493.06 $355,631 - $523,629	1,062 Added 173.81%	1,673 $755,000
Q1 2020 May 04, 2020	BUY	$320.01 - $409.07 $119,043 - $152,174	372 Added 155.65%	611 $214,000
Q4 2019 Feb 06, 2020	BUY	$319.73 - $374.2 $76,415 - $89,433	239 New	239 $88,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.